Mattioli Girolamo, Avanzini Stefano, Pini Prato Alessio, Pio Luca, Granata Claudio, Garaventa Alberto, Conte Massimo, Manzitti Carla, Montobbio Giovanni, Buffa Piero
Pediatric Surgery Department, G. Gaslini Children's Hospital and DINOGMI University of Genoa, Largo G. Gaslini 5, 16147, Genoa, Italy,
Pediatr Surg Int. 2014 Apr;30(4):387-94. doi: 10.1007/s00383-014-3476-z. Epub 2014 Jan 30.
Over the last 20 years MIS has progressively gained popularity in children with cancer. We therefore aimed at evaluating the safety of Minimally Invasive Surgery (MIS) resection in a series of children affected by adrenal neuroblastoma (NB) presenting without Image-Defined Risk Factors (IDRFs).
An Institutional protocol for MIS resection of adrenal NB in pediatric patients without IDRFs has been applied since 2008. Absence of IDRFs represented the main indication for MIS in NB, regardless of tumor size. All pediatric patients who underwent MIS for NB between January 2008 and May 2013 were included. Specific technical considerations, demographic data, and outcome have been recorded.
Twenty-one patients underwent MIS resection for IDRFs-negative adrenal NB. Nine of these patients experienced preoperative downgrading of IDRFs after chemotherapy. Radiological median diameter of the mass was 30 mm (range 10-83 mm). Median operative time was 90 min. Median hospital stay was 4 days. All patients were treated successfully, without serious intraoperative complications. One mild intraoperative hemorrhage occurred and was treated without the need for conversion to open surgery nor blood transfusion was required. No postoperative complications, including port-site or peritoneal metastases were experienced.
This study demonstrated the safety and effectiveness of MIS for the resection of adrenal NB without IDRFs in children. Pediatric surgeons dedicated to oncology should be aware of this alternative approach to open resection.
在过去20年中,微创外科手术(MIS)在癌症患儿中越来越受欢迎。因此,我们旨在评估一系列无影像界定危险因素(IDRFs)的肾上腺神经母细胞瘤(NB)患儿进行微创外科手术(MIS)切除的安全性。
自2008年以来,我们应用了一项针对无IDRFs的儿科患者进行肾上腺NB的MIS切除的机构方案。无论肿瘤大小,无IDRFs是NB中进行MIS的主要指征。纳入了2008年1月至2013年5月间所有接受NB的MIS手术的儿科患者。记录了具体的技术考量、人口统计学数据和结果。
21例患者接受了无IDRFs的肾上腺NB的MIS切除。其中9例患者在化疗后术前IDRFs降级。肿块的放射学中位直径为30mm(范围10 - 83mm)。中位手术时间为90分钟。中位住院时间为4天。所有患者均成功治疗,无严重术中并发症。发生了1例轻度术中出血,无需转为开放手术,也无需输血。未发生包括切口部位或腹膜转移在内的术后并发症。
本研究证明了MIS在儿童无IDRFs的肾上腺NB切除中的安全性和有效性。致力于肿瘤学的儿科外科医生应了解这种替代开放切除的方法。